MDB Capital Holdings, LLC (NASDAQ:MDBH) Short Interest Down 15.9% in February

MDB Capital Holdings, LLC (NASDAQ:MDBH) was the target of a large drop in short interest during the month of February. As of February 13th, there was short interest totaling 1,772 shares, a drop of 15.9% from the January 29th total of 2,107 shares. Based on an average daily trading volume, of 7,165 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.0% of the shares of the company are sold short. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 7,165 shares, the days-to-cover ratio is presently 0.2 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of MDB Capital in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

MDB Capital Stock Up 1.7%

MDB Capital stock traded up $0.05 on Wednesday, hitting $3.02. The company’s stock had a trading volume of 4,764 shares, compared to its average volume of 7,834. MDB Capital has a one year low of $2.80 and a one year high of $6.79. The firm has a market cap of $30.62 million, a P/E ratio of 3.25 and a beta of 1.05. The company has a fifty day moving average price of $3.33 and a 200-day moving average price of $3.47.

Institutional Trading of MDB Capital

A number of hedge funds have recently modified their holdings of the company. Raymond James Financial Inc. acquired a new stake in MDB Capital during the 2nd quarter worth approximately $27,000. DRW Securities LLC acquired a new stake in shares of MDB Capital in the fourth quarter valued at about $40,000. Finally, Citadel Advisors LLC bought a new stake in MDB Capital during the third quarter worth about $43,000. 0.35% of the stock is currently owned by institutional investors and hedge funds.

MDB Capital Company Profile

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.